Despite a number of efforts being put into the radiological protection of both patient and staff during interventional radiological (IR) procedures during recent years, information about radiation exposure during endoscopic retrograde cholangiopancreatography (ERCP) procedures remains scarce. The purpose of this study was to estimate both patient and staff radiation doses during therapeutic ERCP procedures by direct measurement and to compare these results with data from other IR procedures. For 54 patients, effective dose and skin dose were estimated by measuring the dose-area product. For staff, entrance surface doses to the lens of the eye, thyroid and hands were estimated by thermoluminescent dosemeters. A median effective dose of 7.3 mSv and a median entrance surface dose of 271 mGy per procedure were estimated for patients. The gastroenterologist received a median dose of 0.34 mGy to the lens of the eye, 0.30 mGy to the skin at the level of the thyroid and 0.44 mGy to the skin of the hands, per procedure. When comparing the dosimetric quantities presented in this study with data from other IR procedures, it is clear that patient skin doses and doses to staff are high owing to the use of inappropriate X-ray equipment. ERCP requires the same radiation protection practice as all IR procedures. It should be consistently included in future multicentre IR patient and staff dose survey studies at national or international level.

As CT scanners are more routinely used as a guidance tool for various types of interventional radiological procedures, concern has grown for high patient and staff doses. CT fluoroscopy provides the physician immediate feedback and can be a valuable tool to dynamically assist various types of percutaneous interventions. However, the fixed position of the scanning plane in combination with high exposure factors may lead to high cumulative patient skin doses that can reach deterministic threshold limits. The staff is also exposed to a considerable amount of scatter radiation while standing next to the patient during the procedures. Although some studies have been published dealing with this subject, data of patient skin doses determined by direct in vivo dosimetry remains scarce. The purpose of this study is to quantify and to evaluate both patient and staff doses by direct thermoluminescent dosimetry during various clinical CT fluoroscopy guided procedures. Patient doses were quantified by determining the entrance skin dose with direct thermoluminescent dosimetry and by estimating the effective dose (E). Staff doses were quantified by determining the entrance skin dose at the level of the eyes, thyroid, and both the hands with direct thermoluminescent dosimetry. For a group of 82 consecutive patients, the following median values were determined (data per procedure): patient E (19.7 mSv), patient entrance skin dose (374 mSv), staff entrance skin dose at eye level (0.21 mSv), thyroid (0.24 mSv), at the left hand (0.18 mSv), and at the right hand (0.76 mSv). The maximum recorded patient entrance skin dose stayed well below the deterministic threshold level of 2 Gy. Poor correlation between both patient/staff doses and integrated procedure mAs emphasizes the need for in vivo measurements. CT fluoroscopy doses are markedly higher than classic CT-scan doses and are comparable to doses from other interventional radiological procedures. They consequently require adequate radiation protection management. An important potential for dose reduction exists by limiting the fluoroscopic screening time and by reducing the tube current (mA) to a level sufficient to provide adequate image quality.

We evaluated examination protocols used for common CT procedures of paediatric patients at different hospitals in Belgium in order to determine whether adjustments related to patient size are made in scanning parameters, and to compare patient doses with proposed reference levels. Three paediatric hospitals and one non-paediatric hospital participated in the study. Weighted CT dose-index (CTDI(w)), dose-length product (DLP) and effective dose (E) were evaluated for three patient ages (1 year, 5 years and 10 years) and three common procedures (brain, thorax and abdomen). CTDI(w) and DLP values higher than the reference levels were found for all types of evaluated examination. E ranged from 0.4 mSv to 2.3 mSv, 1.1 mSv to 6.6 mSv, and 2.3 mSv to 19.9 mSv for brain, thorax and abdomen examinations, respectively. All centres but one adapted their protocols as a function of patient size. However, no common trend in the selection of protocols was observed. Some centres divided the whole range of patient size into only two/three groups by age, while others classified the patients into six groups by weight. It was also observed that some centres used the same mAs for the total range of patient sizes and decreased the pitch factor for small children, which resulted in higher doses. This indicates the importance of careful selection of technical scan parameters. If CT parameters used for paediatric patients are not adjusted on the basis of examination type, age and/or size of the child, then some patients will be exposed to an unnecessarily high radiation dose during CT examinations.

No abstract